Case File
efta-efta01434422DOJ Data Set 10CorrespondenceEFTA Document EFTA01434422
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01434422
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
EFTA DisclosureText extracted via OCR from the original document. May contain errors from the scanning process.
EFTA01434422
EFTA01434423
Dfin-schc Biif'ik
We.ilih Myrsngemenl
1
[Name of Client]
[Address of Client]
[Address of Client]
[Address of Client]
Deutsche Bank Securities Inc. ("DB") proposes to introduce you to Vy Capital
Management Company
Limited (the "Introduced Party") to discuss the possibility of, if you deem
it suitable, your investing in
interests in Space Exploration Technologies Corp,. (the "Interests"),
DB is not offering, selling or recommending your investment in the Interests
and does not act as agent
for the Introduced Party or issuer of the Interests. You must make an
independent assessment of the
opportunities and risks presented by the potential investment in the
Interests, including relevant market
factors and other investment considerations, such as tax impact
If you elect to invest in the Interests. DB will be paid a referral fee by
the Introduced Party equal to 2%
of the capital or assets you commit to invest in the Interests. As a result,
DB may have an incentive
to introduce you to the Introduced Party in connection with investment in
the Interests, ahead of other
possible Introduced Parties and investments for which DB would not receive a
referral fee,
You will not pay a higher subscription amount for the Interests as a result
of our arrangement. This
arrangement, however, may affect the Introduced Party's willingness to
negotiate below its standard
placement fees, as applicable, and as a result may affect the overall fees
introduced clients pay.
Please sign below to evidence your acknowledgment of this Disclosure Letter
and of the disclosures
included herein and your confirmation that you are capable of evaluating the
proposed investment and
have determined or, prior to investing, will determine, that it is suitable
for you.
ACKNOWLEDGMENT OF RECEIPT
I acknowledge receipt of this Disclosure Letter from DB describing the
arrangements between DB and
the Introduced Party, I also acknowledge that the Interests are "restricted"
and, thus, illiquid and may
be subject to restrictions on redemption I also understand that DB is not
recommending, offering or
EFTA01434424
selling the Interests to me and is not involved in the placement of the
Interests. I confirm that: (I) 1
have greater than $50 miliion in net assets, (II) I have experience
investing in investments similar to
interests in the Interests, (iii) I am capable of independently evaluating
the inherent investment risk in
the Interests and (iv) prior to investing in the Interests, I have or will
have evaluated the investment
and determined that it is a suitable investment for me.
[o I (A-
f- Bdk
Signature
BA1R16T
Printed Name
capital
NON-DISCLOSURE AGREEMENT
Effective Date; October 3,2017
Participant Company: Vy Capital Management Company Limited
Participant Address: Emirates Financial Towers,
South Tower, Level 9, Office 901/902
DiFC, PO Box 506950, Dubai, UAE
extent: (i) it is required to do so by law, provided that Recipient gives
Discloser sufficient notice to enable it to seek an order limiting or
precluding such disclosure, and/or in any event only disclose the exact
Confidential information, or portion thereof, specifically requested; or
(ii) Discloser gives its prior written authorization to do so which is
signed by an officer of the Discloser. Recipient agrees that except to
the extent that the Discloser is expressly precluded by iaw from
prohibiting Recipient from doing so, Recipient shall not alter, modify,
adapt, create derivative works, translate, deface, decompile,
disassemble, convert into human readable form, or reverse engineer
all, or any part, of any materials to which it is provided access by
Discloser.
5. Confidentiality Period: Recipient's duties with respect to
Confidential Information under this Agreement shall continue for two
(2) years from the expiration or termination of this Agreement for any
reason (except for source code and frade secrets, which shall remain
subject to the terms of this Agreement so long as they constitute
source code or trade secrets under applicable law),
6, Standard of Care: Recipient shall treat Confidential Information as
strictly confidential, and shall use the same standard of care to prevent
unauthorized use, reproduction, or disclosure as the Recipient uses to
protect its own confidential and proprietary information of a similar
nature, but in no event less than reasonable care.
7. Exclusions: Information foal Recipient can establish: (a) was
lawfully in Recipient's possession before receipt from Discloser; or (b)
is or becomes a matter of public knowledge through no fault of
Recipient; or (c) was independently developed or discovered by
Recipient without the benefit of any Confidential Information of the
Disclosing Party, shall not be considered Confidential Information
EFTA01434425
under this Agreement.
8. Warranty: This Agreement shall not obligate either Party to disclose
any Confidential Information with the other Party. Discloser makes no
representation, warranty or guarantee whatsoever about the
Confidential Information.
9. Ownership: The Recipient hereby acknowledges and agrees that
it shall not acquire any rights in or to the Confidential Information under
this Agreement other than the rights granted in Paragraph 4. In
particular. Recipient shall not acquire any ownership right, interest, or
title in or to the Confidential Information or any intellectual property
rights therein or the right to obtain or apply for such rights under the
Agreement. Nothing contained herein shall be construed as obligating
either Party to (i) disclose any Confidential Information to the other or
(ii) enter into a business relationship with the other.
to. Rights and Remedies: Recipient further acknowledges and
agrees that due to the unique nature of the Disclosing Party's
Confidential Information, there can be no adequate remedy at law for
any breach of its obligations hereunder, that any such breach may
allow the Recipient or third parties to unfairly compete with the
Disclosing Party resulting in irreparable harm to the Disclosing Party
and, therefore, that upon any such breach or any threat thereof, the
Disclosing Party shall be entitled to seek injunotive relief under this
Agreement, without the necessity of proving actual damages or
posting bonds, in addition to any other relief as may be granted by a
This Non-Disclosure Agreement ("Agreement") is entered by and
between the undersigned and Vy Capital ("VyC") identified above
(each a "Party" and together the "Parties"). In order to protect certain
Confidential Information as described below, the parties agree as
follows:
1. Disclosing Party: The Party disclosing the Confidential information
(the "Discloser") is VyC.
iPescription of Confidential Information: "Confidential
Information" is any information in wliatever form or medium (and
includes any copies of such information that receiving Party
("Recipient") is authorized to make hereunder) that is; (a) proprietary
or confidential to Discloser or its affiliated companies or to their
respective customers, suppliers or other business partners, including
without limitation, information that is embedded in or related to the
Discloser's product or the development, testing, or commercial
exploitation thereof, in whatever form or media; (b) is either specifically
identified as confidential prior to or at the time of its disclosure or would
generally be considered confidential by the Recipient, exercising
reasonable judgment and (c) directly or indirectly disclosed or to which
the Recipient is otherwise provided access by Discloser or on
Discloser's behalf. For the purposes of clarification, in relation to any
discussions relating to patent rights, any prior art identified by
Discloser as a result of Discloser expending time and/or money shall
constitute Confidential Information and may be used, reproduced or
disclosed only as specifically provided herein.
3. Purpose: In this Agreement. "Purpose" means; (i) assessing the
desirability or viability of establishing or furUiering a business
EFTA01434426
contractual relationship between the Parties, and (ii) to the extent this
Agreement is incorporated by reference into any other agreement,
achieving the objectives of that agreement.
4. Use, Disclosure, and Reproduction. Except as specifically
provided herein, Recipient shall hold Confidential Information in strict
confidence. Recipient shall use and reproduce the Confidential
Information only to the extent reasonably required to fulfill the Purpose,
It shall not be a breach of the obligations of the Recipient if the
Recipient provides access to Confidential information to, and
authorizes the use and reproduction of the Confidential Information as
is reasonable required to fulfill the Purpose by the Recipient's
employees ("Employees"), provided that Recipient is vicariously liable
for the failure of any Employee to whom Confidential Information is
disclosed to comply with Recipient's obligations hereunder and ftjrther
provided that the Employee: (i) has a need to know the Confidential
Information to fulfill the Purpose and (ii) is clearly informed by
Recipient of the confidential nature of Confidential Information.
Recipient may also disclose Confidential Information if and only to the
court of competent jurisdiction. If any legal action is brought to enforce
any obligations hereunder, the prevailing party shall be entitled to
receive reasonable attorneys' fees, court costs and other collection
expenses, in addition to any other relief it may receive.
11. Relationship between the Parties: This Agreement does not
create any agency, partnership, employment or joint venture
relationship between the Parties.
12. Entire Agreement: This Agreement constitutes the entire
agreement of Parties with respect to the subject matter of this
Agreement and cancels and supersedes any prior discussions,
correspondence, understandings, agreements, or communication of
any nature relating to the subject matter of this Agreement, Any
waiver, modification, amendment, supplement or other change to this
Agreement must be in writing and signed by both Parties.
13. Assignment: This Agreement may not be assigned by Recipient
without Oiscloser's express prior written authorization. Subject to the
foregoing, this Agreement shall inure to the benefit of and be binding
upon the Parties, and their permitted successors and assigns,
14. Return of Confidential Information: Upon expiration or
termination of this Agreement, at the Discloser's request, the
Recipient shall promptly (a) return or destroy all Confidential
Information received from the Discloser (including, without limitation,
any summaries of orally disclosed information and all copies thereof
in its possession or control), and all materials which incorporate or
are based on Confidential Information prepared by Recipient, and (b)
certify through an officer of the Recipient to Disclosing Party that all
Confidential Information have been returned or destroyed. Failure of
the Discloser to make such request of Recipient shall not entitle
Recipient to make any further use of toe Confidential Information or
otherwise extend Recipient's right set forth herein after expiration or
termination of this Agreement and Recipient specifically agrees to
cease any further use of Oiscloser's Confidential Information.
15. Severability: if a court of competent jurisdiction declares any
EFTA01434427
provision in this Agreement invalid or unenforceable, such invalidity
or unenforceability shall have no effect on toe remainder of the
Agreement which shall remain in full force. No delay, failure, or
waiver of either party's exercise or parfial exercise of any right or
remedy under this Agreement shall operate to limit, impair, preclude,
cancel, waive or otherwise affect such right or remedy. No waiver of
any provision of this Agreement shall constitute a waiver of any other
provision(s) or of the same provision on anotoer occasion.
16. Counterparts: This Agreement may be signed in two
counterparts each of which together will be deemed to be an original
and all of which together will constitute one and toe same instrument.
17. Notices: Any notice under this Agreement shall be in writing and
shall be effecti ve only if it is delivered by hand or mailed, certified or
registered mail, postage prepaid, return receipt requested, addressed
to the appropriate party at its address set forth in this Agreement.
Any such notice shall be effective only upon actual receipt by the
party to be notified.
18. Governing Law: This Agreement shall be construed and
governed by English law, The parties hereby submit to the personal
jurisdiction of, and agree that any legal proceeding with respect to or
arising under this Agreement shall be brought solely to the London
Court of International Arbitration (LCIA) Each Party hereto
irrevocable waives any objections on the grounds of venue, forum
non-conveniens, or any similar grounds.
19. Pubtic Informatioiv. Without Recipient's prior written consent,
the Company shall not provide to Recipient or its affiliates, directors.
officers, employees, consultants or agents any material non-public
information about any company that has its or its affiliates' securities
listed in any public exchange that would restrict Recipient's ability to
fiade securities.
[X]:
Participant: Vy Capital Management Company Limited
By:
By;
Printed Name: [x] -pftOL
Title: [xj
1
Printed Name: Daniel Schwarz
Title: Chief Operating Officer
EFTA01434428
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.